PrimaGenics

Bengaluru, India Founded: 2015 • Age: 11 yrs Minicorn
Private label healthcare supplements are distributed via an online store.

About PrimaGenics

PrimaGenics is a Healthcare company based in Bengaluru (India) founded in 2015. Private label healthcare supplements are distributed via an online store. PrimaGenics has raised $139.03 thousand across 1 funding round from investors including Nimrod Brokman. PrimaGenics was last valued at $1.72 million in May 2020. Its Indian entity Potential Health Development Private Limited reported revenue of β‚Ή2.50 Cr. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its competitors include Kapiva, Setu and BBetter; 3 of its 3 listed competitors have raised funding.

Company details

PrimaGenics was established in 2015 in Bengaluru, India, within the healthcare supplements sector. A private label approach is utilized for products encompassing antioxidants, bone health aids, general wellness items, weight management options, and specialized formulations for men and women. An online store facilitates direct sales. All manufacturing is conducted by Sansha Care to ensure production standards.

Key Metrics
  • Annual Revenue
    ₹2.50 Cr

    FY 2025 · +85% YoY

  • Net Profit
    ₹7.5 Lakh

    FY 2025 · 3% margin

  • EBITDA
    ₹52.4 Lakh

    FY 2025 · 21% margin

  • Total Equity Funding
    $139.03K (USD)

    in 1 rounds

  • Latest Funding Round
    $139.03K (USD), Angel Round

    May 2020

Funding Insights of PrimaGenics

PrimaGenics has successfully raised a total of $139.03K through 1 strategic funding round. The most recent funding activity was a Angel Round of $139.03 thousand completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $139,034
  • Total Rounds 1
  • Last Round Angel Round β€” $139,034
  • First Round $139,034

    (May 2020)

  • Investors Count 1

All 1 funding rounds of PrimaGenics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2020$139,034Angel Round$1.72MNimrod Brokman
–
Valuation history
DateValuationStage
May 2020$1.72Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.72M (May 2020). 1 investors in total: 0 institutional and 1 angel.

Investors in PrimaGenics

PrimaGenics has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Nimrod Brokman.

All
Angel
InvestorDescriptionFounded YearDomainLocation

Nimrod Brokman

unknown_668e93a5833a46789
Premium access

Investor details for PrimaGenics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Potential Health Development Private Limited (PrimaGenics)

Potential Health Development Private Limited is the primary company behind PrimaGenics. The board of Potential Health Development Private Limited currently have 3 directors; the longest-serving is Shiva Subramanian, appointed in 2014.

DirectorDesignationAppointedTenureEntity
Shiva Subramanian
DIN 00445134
Director21 Aug 201412 yrs 2 moPotential Health Development Private Limited
Nandita Abreo Subramanian
DIN 05181149
Director21 Aug 201412 yrs 2 moPotential Health Development Private Limited
Alia Marie Abreo Prabhu
DIN 08857287
Director20 Sep 20206 yrs 1 moPotential Health Development Private Limited

Financials of PrimaGenics

Figures of Potential Health Development Private Limited, the primary company behind PrimaGenics, for FY 2025. Revenue was ₹2.50 Cr (+85% year on year). Net profit was ₹7.5 Lakh (3% margin). EBITDA was ₹52.4 Lakh (21% margin). Revenue has grown at a compounded annual rate of +7% over three years and +25% over five years.

  • ₹2.50 CrRevenue · FY 2025 · +85% YoY
  • ₹7.5 LakhNet profit · 3% margin
  • ₹52.4 LakhEBITDA · 21% margin
  • ₹10 LakhPaid-up capital
  • +7%Revenue CAGR, 3 years
  • +25%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Potential Health Development Private Limited are on its company page.

Premium access

Detailed financial statements for PrimaGenics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of PrimaGenics

3 dated milestones of PrimaGenics across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded PrimaGenics is founded.
  2. Funding First funding round of $139K.
  3. Milestone Reaches Minicorn status.

Competitors of PrimaGenics

PrimaGenics has 3 listed competitors in our database, 3 of them funded. They include Kapiva, Setu and BBetter.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
kapiva.in2016Bengaluru, India$77.85M492
Ayurvedic healthcare and nutritional products are provided by Kapiva.
setu.in2017Mumbai, India$1.72M200
Dietary supplements with herbal extracts and vitamins are provided.
bbetter.co2018Hyderabad, India$1.89M151
Nutritional supplements are provided to enhance health and wellness.
Premium access

Detailed competitors of PrimaGenics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as PrimaGenics (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PrimaGenics

PrimaGenics was founded in 2015 and raised its 1st funding round 5 years after it was founded.

PrimaGenics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

PrimaGenics is a funded company, having raised a total of $139.03K across 1 funding round to date. The company's 1st funding round was a Angel Round of $139.03K, raised on May 2020.

The primary company behind PrimaGenics, Potential Health Development Private Limited, reported revenue of β‚Ή2.50 Cr for FY 2025, up 85% year on year.

PrimaGenics was established in 2015 in Bengaluru, India, within the healthcare supplements sector. A private label approach is utilized for products encompassing antioxidants, bone health aids, general wellness items, weight management options, and specialized formulations for men and women. An online store facilitates direct sales. All manufacturing is conducted by Sansha Care to ensure production standards.

PrimaGenics's top competitors include Kapiva, Setu and BBetter.

PrimaGenics has 1 investor. Key investors include Nimrod Brokman.

The valuation of PrimaGenics is $1.72M as of May 2020.

PrimaGenics operates through Potential Health Development Private Limited.

The legal entities of PrimaGenics currently have 3 directors, including Shiva Subramanian, Nandita Abreo Subramanian, Alia Marie Abreo Prabhu.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available